Mylan Institutional LLC recalls Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per c
Recalled August 19, 2015 · FDA recall D-1329-2015 · Mylan Institutional
Hazard
Presence of Particulate Matter · FDA Class I
Units
8,340 vials
Sold at
Nationwide
Description
Presence of Particulate Matter
Product
Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per carton (NDC 0069-0152-02), Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017.
Manufacturer(s)
Mylan Institutional LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →